18 April 2024
DUKEMOUNT CAPITAL PLC
("DUKEMOUNT" or the "Company")
RESULTS OF ANNUAL GENERAL MEETING, CAPITAL REORGANISATION, ADMISSION OF NEW ORDINARY SHARES AND TOTAL VOTING RIGHTS
Dukemount Capital Plc announces that its annual general meeting ("AGM") has been held today at 10:00 a.m. All resolutions set out in the AGM circular dated 21 March 2024 have been approved.
Following the approval of the capital reorganisation ("Capital Reorganisation") at the AGM, applications were made to the FCA and the London Stock Exchange for the Capital Reorganisation to be reflected on the Official List. It is expected that 969,316,623 ordinary shares of £0.00001 ("New Ordinary Shares") each will be admitted to trading and dealings will commence on the London Stock Exchange at or around 8:00 a.m. 19 April 2024.
The New Ordinary Shares have the same rights as the existing ordinary shares, including voting, dividend, and other rights.
In addition, following the AGM, the Company can now issue 750,000,000 New Ordinary Shares ('Subscription Shares') at a price of £0.0004 per share (the 'Subscription Price'), with one warrant attached to each Subscription Share ("Subscription Warrants"), to Paul Gazzard, a director of Dukemount to raise £300,000. Immediately following admission of the Subscription Shares to the Official List of the UK Listing Authority by way of a Standard Listing ("Admission"), Mr Gazzard has agreed to sell the Subscription Shares and the Subscription Warrants, at the Subscription Price to unconnected investors.
Next Steps
Following the previous announcement of the capitalisation of loans on March 4, 2024, and the £300,000 fundraise, the Company is now in a stronger position to pursue potential strategic opportunities through a reverse takeover.
The Board plans to take a thematic approach, concentrating on identifying topical sectors with potential for significant capital growth. This will involve reviewing opportunities of various sizes and, if appropriate, seeking a listing on AIM. The Board hopes to update shareholders further as matters progress. However, at this stage, there can be no certainty that a reverse takeover will take place and any such transaction will, inter alia, require shareholder approval.
Applications have been made to the FCA and the LSE for the admission of the Subscription Shares ("Admission"). It is expected that 750,000,000 New Ordinary Shares of £0.00001 each will be admitted to trading and dealings will commence on the LSE at or around 8:00 a.m. 19 April 2024.
Following Admission, the Company will have 1,719,316,623 New Ordinary Shares of £0.00001 each in issue, none of which are held in treasury. Therefore, the total number of voting rights in the Company is 1,719,316,623.
The above figure of 1,719,316,623 may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.
For further information, please visit www.dukemountcapitalplc.com or contact:
Company
Dukemount Capital Plc: info@dukemountplc.com
Paul Gazzard (CEO)
Geoffery Dart (Non-Executive Director)
Corporate Broker
Peterhouse Capital Limited +44 (0) 207 469 0930
Lucy Williams/Duncan Vasey
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
1 | Details of the person discharging managerial responsibilities / person closely associated | |
a) | Name | Paul Gazzard |
2 | Reason for the notification | |
a) | Position/status | Chief Executive Officer |
b)
| Initial notification /Amendment | Initial notification |
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
a) | Name | Dukemount Capital plc |
b) | LEI | 213800IVPZ932NP24O44 |
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
a)
| Description of the financial instrument, type of instrument Identification code | Ordinary Shares of £0.00001 each
ISIN: GB00BMWC6Q55 |
b) | Nature of the transaction | £300,000 Subscription for 750,000,000 new ordinary shares |
c) | Price(s) and volume(s) | Price No. of shares £0.0004 750,000,000 |
d) | Aggregated information - Aggregated volume - Price |
750,000,000 £0.0004 |
e) | Date of the transaction | 19 April 2024 |
f) | Place of the transaction | Outside a trading venue |
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
1 | Details of the person discharging managerial responsibilities / person closely associated | |
a) | Name | Paul Gazzard |
2 | Reason for the notification | |
a) | Position/status | Chief Executive Officer |
b)
| Initial notification /Amendment | Initial notification |
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
a) | Name | Dukemount Capital plc |
b) | LEI | 213800IVPZ932NP24O44 |
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
a)
| Description of the financial instrument, type of instrument Identification code | Ordinary Shares of £0.00001 each
ISIN: GB00BMWC6Q55 |
b) | Nature of the transaction | Disposal of 750,000,000 new ordinary shares |
c) | Price(s) and volume(s) | Price No. of shares £0.0004 750,000,000 |
d) | Aggregated information - Aggregated volume - Price |
750,000,000 £0.0004 |
e) | Date of the transaction | 19 April 2024 |
f) | Place of the transaction | Outside a trading venue |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.